Advances in the treatment of non-Hodgkin's lymphoma

Ann Oncol. 2002:13 Suppl 4:211-6. doi: 10.1093/annonc/mdf662.

Authors

T Cerny¹, S Gillessen

Affiliation

¹ Department of Internal Medicine, Division of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.

PMID: 12401693
DOI: 10.1093/annonc/mdf662

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Biopsy, Needle
Bone Marrow Transplantation
Combined Modality Therapy
Female
Graft Survival
Humans
Immunotherapy / methods*
Lymphoma, B-Cell, Marginal Zone / mortality
Lymphoma, B-Cell, Marginal Zone / pathology
Lymphoma, B-Cell, Marginal Zone / therapy
Lymphoma, Non-Hodgkin / mortality
Lymphoma, Non-Hodgkin / pathology*
Lymphoma, Non-Hodgkin / therapy*
Male
Neoplasm Staging
Prognosis
Quality of Life*
Randomized Controlled Trials as Topic
Risk Assessment
Survival Rate
Time Factors
Treatment Outcome

Substances

Antibodies, Monoclonal